1. Home
  2. LQDA vs HLIT Comparison

LQDA vs HLIT Comparison

Compare LQDA & HLIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LQDA
  • HLIT
  • Stock Information
  • Founded
  • LQDA 2004
  • HLIT 1988
  • Country
  • LQDA United States
  • HLIT United States
  • Employees
  • LQDA N/A
  • HLIT N/A
  • Industry
  • LQDA Biotechnology: Pharmaceutical Preparations
  • HLIT Radio And Television Broadcasting And Communications Equipment
  • Sector
  • LQDA Health Care
  • HLIT Technology
  • Exchange
  • LQDA Nasdaq
  • HLIT Nasdaq
  • Market Cap
  • LQDA 1.3B
  • HLIT 1.2B
  • IPO Year
  • LQDA 2018
  • HLIT 1995
  • Fundamental
  • Price
  • LQDA $14.03
  • HLIT $10.30
  • Analyst Decision
  • LQDA Strong Buy
  • HLIT Buy
  • Analyst Count
  • LQDA 7
  • HLIT 6
  • Target Price
  • LQDA $26.67
  • HLIT $12.50
  • AVG Volume (30 Days)
  • LQDA 886.3K
  • HLIT 1.4M
  • Earning Date
  • LQDA 05-12-2025
  • HLIT 04-28-2025
  • Dividend Yield
  • LQDA N/A
  • HLIT N/A
  • EPS Growth
  • LQDA N/A
  • HLIT N/A
  • EPS
  • LQDA N/A
  • HLIT 0.33
  • Revenue
  • LQDA $15,610,000.00
  • HLIT $678,722,000.00
  • Revenue This Year
  • LQDA N/A
  • HLIT N/A
  • Revenue Next Year
  • LQDA $208.28
  • HLIT $22.41
  • P/E Ratio
  • LQDA N/A
  • HLIT $31.18
  • Revenue Growth
  • LQDA N/A
  • HLIT 11.65
  • 52 Week Low
  • LQDA $8.26
  • HLIT $8.42
  • 52 Week High
  • LQDA $16.99
  • HLIT $15.46
  • Technical
  • Relative Strength Index (RSI)
  • LQDA 40.61
  • HLIT 44.67
  • Support Level
  • LQDA $13.50
  • HLIT $9.87
  • Resistance Level
  • LQDA $14.61
  • HLIT $10.50
  • Average True Range (ATR)
  • LQDA 0.71
  • HLIT 0.34
  • MACD
  • LQDA -0.27
  • HLIT 0.07
  • Stochastic Oscillator
  • LQDA 19.70
  • HLIT 50.00

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

About HLIT Harmonic Inc.

Harmonic Inc engaged in broadband access solutions that enable broadband operators to more efficiently and effectively deploy high-speed internet for data, voice, and video services for their customers and versatile and high-performance video delivery software, products, system solutions and services that enable its customers to efficiently create, prepare, store, playout and deliver a full range of high-quality broadcast and streaming video services to consumer devices, including televisions, personal computers, laptops, tablets, and smartphones. It has two segments, Broadband which provides broadband access solutions and related services, and Others; and Video business provides video processing and production and playout solutions and services, and Others.

Share on Social Networks: